Search

Your search keyword '"Beta-Cryptoxanthin"' showing total 259 results

Search Constraints

Start Over You searched for: Descriptor "Beta-Cryptoxanthin" Remove constraint Descriptor: "Beta-Cryptoxanthin"
259 results on '"Beta-Cryptoxanthin"'

Search Results

151. Comparison of Australian Recommended Food Score (ARFS) and Plasma Carotenoid Concentrations: A Validation Study in Adults

152. β-Cryptoxanthin Inhibits Angiogenesis in Human Umbilical Vein Endothelial Cells Through Retinoic Acid Receptor

153. The high content of β-carotene present in orange-pulp fruits of Carica papaya L. is not correlated with a high expression of the CpLCY-β2 gene

154. β-Cryptoxanthin ameliorates metabolic risk factors by regulating NF-κB and Nrf2 pathways in insulin resistance induced by high-fat diet in rodents

155. Serum carotenoids and colorectal cancer risk: A case-control study in Guangdong, China

156. Xanthophyll β‐Cryptoxanthin Inhibits Highly Refined Carbohydrate Diet–Promoted Hepatocellular Carcinoma Progression in Mice

157. EFFECT OF CITRUS FLAVANONES ON CAROTENOID UPTAKE BY INTESTINAL CACO-2 CELLS

158. Keeping an Eye on Lutein Stability

159. Beta-Cryptoxanthin Inhibits Lipopolysaccharide-Induced Osteoclast Differentiation and Bone Resorption via the Suppression of Inhibitor of NF-κB Kinase Activity

160. Gene expression analysis of enzymes of the carotenoid biosynthesis pathway involved in β-cryptoxanthin accumulation in wild raspberry, Rubus palmatus

161. Variations in native protein glycation and plasma antioxidants in several birds of prey

162. Metabolic and transcriptional elucidation of the carotenoid biosynthesis pathway in peel and flesh tissue of loquat fruit during on-tree development

163. Plasma Carotenoids, Tocopherols, and Retinol in the Age-Stratified (35–74 Years) General Population: A Cross-Sectional Study in Six European Countries

164. Carotenoids as biomarkers of fruit and vegetable intake in men and women

165. In Vitro Inhibition of Human UDP-Glucuronosyl-Transferase (UGT) Isoforms by Astaxanthin, β-Cryptoxanthin, Canthaxanthin, Lutein, and Zeaxanthin: Prediction of in Vivo Dietary Supplement-Drug Interactions

166. Influence of nutrition on the decline of ovarian reserve and subsequent onset of natural menopause

167. Protective Efficacy of the Ingestion of Mandarin Orange Containing β-Cryptoxanthin on Lipopolysaccharide-induced Acute Nephritis

168. Modelling the growth kinetics of Kocuria marina DAGII as a function of single and binary substrate during batch production of β-Cryptoxanthin

169. Novel Action of Carotenoids on Non-Alcoholic Fatty Liver Disease: Macrophage Polarization and Liver Homeostasis

170. High serum carotenoids are associated with lower risk for developing elevated serum alanine aminotransferase among Japanese subjects: the Mikkabi cohort study

171. Carotenoid intake and adipose tissue carotenoid levels in relation to prostate cancer aggressiveness among African-American and European-American men in the North Carolina-Louisiana prostate cancer project (PCaP)

173. Health Promotion by Antioxidants

174. Prevention of NAFLD/NASH by Astaxanthin and β-Cryptoxanthin.

175. β-Cryptoxanthin from Satsuma Mandarin and Its Multiple Functions.

176. Effects of .BETA.-cryptoxanthin-fortified Satsuma Mandarin (Citrus unshiu Marc.) Juice on Liver Function and the Serum Lipid Profile

177. Addition of either gastric lipase or cholesterol esterase to improve both β-cryptoxanthin ester hydrolysis and micellarization during in vitro digestion of fruit pulps.

178. A hypocaloric high-protein diet supplemented with β-cryptoxanthin improves non-alcoholic fatty liver disease: a randomized controlled trial.

179. In vitro digestion-assisted development of a β-cryptoxanthin-rich functional beverage; in vivo validation using systemic response and faecal content

180. Association between intake of antioxidants and pancreatic cancer risk: a meta-analysis

181. Beta-Cryptoxanthin Inhibits Lipopolysaccharide-Induced Osteoclast Differentiation and Bone Resorption via the Suppression of Inhibitor of NF-κB Kinase Activity.

182. Consumption of canned citrus fruit meals increases human plasma β-cryptoxanthin concentration, whereas lycopene and β-carotene concentrations did not change in healthy adults

183. Lung Cancer Mortality and Serum Levels of Carotenoids, Retinol, Tocopherols, and Folic Acid in Men and Women: a Case-Control Study Nested in the JACC Study

184. AOAC SMPR® 2016.004

185. Plasma Carotenoid Levels in Relation to Tobacco Smoking and Demographic Factors

186. Antioxidant β-cryptoxanthin enhances porcine oocyte maturation and subsequent embryo development in vitro

187. Conversion of Intravenously Administered .BETA.-Cryptoxanthin to a .BETA.-Carotene-Like Compound in Mouse Lung

188. β-Cryptoxanthin exerts greater cardioprotective effects on cardiac ischemia-reperfusion injury than astaxanthin by attenuating mitochondrial dysfunction in mice

189. Xanthophyll esters are found in human colostrum

190. BETA-CRYPTOXANTHIN EXERTS BETTER CARDIOPROTECTION AGAINST CARDIAC ISCHEMIA-REPERFUSION INJURY THAN ASTAXANTHIN VIA PROTECTING MITOCHONDRIAL DYSFUNCTION IN MICE

192. Quantitative Analysis of .BETA.-Cryptoxanthin in Satsuma Mandarin (Citrus unshiu Marc.) Juice by C30 Stationary Phase High Performance Liquid Chromatography

193. Inhibitory Effects of .BETA.-Cryptoxanthin Rich Powder Prepared from Satsuma Mandarin (Citrus unshiu Marc.) Juice on Azoxymethane-induced Aberrant Crypt Foci of Rats

194. Serum carotenoid levels and risk of lung cancer death in US adults

195. Effect of alcoholic fermentation on the carotenoid composition and provitamin A content of orange juice

197. Reinterpretation of the results of a pooled analysis of dietary carotenoid intake and breast cancer risk by using the interval collapsing method

198. β‐Cryptoxanthin and lutein mediate inflammatory mediators and cytokines in human chondrosarcoma cells induced with interleukin‐1β

Catalog

Books, media, physical & digital resources